Anzeige
Mehr »
Login
Donnerstag, 16.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Victoria Gold: Fulminanter Aufstieg zum Produzenten und Analysten-Favorit! Hohe Kursziele!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
59 Leser
Artikel bewerten:
(0)

Medical Marijuana Inc.'s & Dixie Elixir's Tripp Keber, to Appear on Sirius XM Radio's iCannabis Channel Tonight

SAN DIEGO, Aug. 7, 2012 /PRNewswire/ --Medical Marijuana Inc. (OTC: MJNA), a leading hemp industry innovator, is pleased to inform its shareholders that Board Member, Tripp Keber will appear on the Sirius XM Radio Network's iCannabis Channel this evening. The program will begin at 7pm Mountain Time.

Mr. Keber, managing director for Dixie Elixirs & Edibles, will appear on tonight's Realm of Caring American Weed show on the iCannabis Radio channel, which is available on Sirius XM satellite radio and on internet radio. The internet radio link is provided below. Mr. Keber will speak about the Colorado-based Dixie Elixirs company as well as the successful launch of the Dixie X high concentration hemp-based CBD-infused product line. Mr. Keber will also describe the mutually beneficial relationship that Dixie has with Medical Marijuana Inc.

A link to the program available on the internet would be found here:
http://www.icannabisradio.com/American-Weed--The-Realm.html

If you are unable to listen in live at 7pm Mountain, 9pm Eastern, 8pm Central or 6pm Pacific, the show will be archived for future listening.

Get a preview of tonight's show featuring Mr. Keber here (the link starts in at 27min):
http://www.youtube.com/watch?v=E6U6dhBwB1A&t=27m1s

About Medical Marijuana, Inc.

Our mission is to be the premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate and purchase value-added companies and products, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, develop environmentally friendly, economically sustainable businesses, while increasing shareholder value.

Medical Marijuana Inc. does not grow, sell or distribute any substances that violate United States Law or the controlled substance act.

For more information, please visit the company's website at: www.MedicalMarijuanaInc.com.

FORWARD-LOOKING DISCLAIMER

This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.

Corporate Contact:
Medical Marijuana, Inc.
Toll Free: 888-OTC-MJNA (888-682-6562)

www.medicalmarijuanainc.com
www.facebook.com/mjnainc

Investor Relations Contact:
Stuart T. Smith
SmallCapVoice.Com, Inc.
P. 512-267-2430
F. 512-267-2530
Email: ssmith@smallcapvoice.com
Skype: SmallCapVoice.com
AIM: SmallCapVoice7

SOURCE Medical Marijuana Inc.

KI-Champions: 3 Top-Werte, die Ihr Portfolio revolutionieren
Fordern Sie jetzt den brandneuen kostenfreien Sonderreport an und erfahren Sie, wie Sie von den enormen Wachstumschancen im Bereich Künstliche Intelligenz profitieren können - 100 % kostenlos.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.